Intellia Therapeutics, Inc. (NTLA) › Shares OutstandingIntellia Therapeutics, Inc. (NTLA) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2015: 2.56M2016: 36.02M2017: 42.38M2018: 45.22M2019: 50.20M2020: 66.23M2021: 74.49M2022: 87.10M2023: 93.00M2024: 102.03M2025: 116.32M116.32M2015Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025116.32M+14.0%2024102.03M+9.7%202393.00M+6.8%202287.10M+16.9%202174.49M+12.5%202066.23M+31.9%201950.20M+11.0%201845.22M+6.7%201742.38M+17.7%201636.02M+1307.7%20152.56M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share